J Lung Cancer.  2012 Dec;11(2):89-93. 10.6058/jlc.2012.11.2.89.

Never-Smoker Lung Cancer Is Increasing

Affiliations
  • 1Lung and Esophageal Cancer Clinic, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. kyc0923@jnu.ac.kr
  • 2Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
  • 3Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School, Gwangju, Korea.
  • 4Department of Radiation Oncology, Chonnam National University Medical School, Gwangju, Korea.
  • 5Department of Pathology, Chonnam National University Medical School, Gwangju, Korea.
  • 6Department of Radiology, Chonnam National University Medical School, Gwangju, Korea.
  • 7Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea.

Abstract

PURPOSE
Lung cancer has been the leading cause of death in South Korea since the year 2000. Adenocarcinoma became the most frequent type in the national survey of lung cancer since year 2005.
MATERIALS AND METHODS
We analyzed 5,456 cases with lung cancer from 2004 to 2012 in a community cancer center. The mean age was 69.9 years, and 78.9% was male.
RESULTS
Adenocarcinoma (ADC, 40.8%) was the most frequent type, followed by squamous cell carcinoma (SQC, 36.4%), small cell carcinoma (SCC, 14.8%) and non-small cell lung cancer (NSCLC) not otherwise specified (8.1%). In male patients, SQC was the most frequent type (43.5%), while ADC showed highest incidence in females (72.6%). Anatomic stage at diagnosis in NSCLC was I (10.3%), II (5.8%), IIIA (15.7%), IIIB (19.2%), and IV (49.0%). In SCC, 41.7% was in limited stage and 58.3% was diagnosed in extensive stage. The proportion of never smoker has been increased from 19.1% in 2004~2008 to 25.4% in 2009~2012. Never-smokers are more likely to be female (68.2% vs. 4.0%, p<0.001), have ADC (69.9% vs. 31.3%, p<0.001), and manifest as stage IV disease (58.5% vs. 45.2%, p<0.001), compared to smokers. Among 1,908 cases whose initial treatment was recorded, 42.5% received chemotherapy, 25.7% received radiation treatment, 20.5% received surgery and the remaining 11.3% received supportive cares only or transferred to other health care facilities.
CONCLUSION
In conclusion, proportion of lung cancer in never-smoker is increasing. As screening for smokers will miss this growing population, we need to discover biomarkers to find high risk population of lung cancer.

Keyword

Lung neoplasms; Epidemiology; Smoking; Female

MeSH Terms

Adenocarcinoma
Biomarkers
Carcinoma, Non-Small-Cell Lung
Carcinoma, Small Cell
Carcinoma, Squamous Cell
Cause of Death
Delivery of Health Care
Female
Humans
Incidence
Lung
Lung Neoplasms
Male
Mass Screening
Republic of Korea
Smoking

Figure

  • Fig. 1 Proportion of lung cancer histologic types from year 2004 to 2012. ADC: adenocarcinoma, NSC: non-small cell carcinoma, not otherwise specified, SCC: small cell carcinoma, SQC: squamous cell carcinoma.

  • Fig. 2 Proportion of stage (I, II, IIIA, IIIB, and IV) at diagnosis in squamous cell carcinoma (SQC; 8.9%, 7.3%, 22.8%, 28.0%, 33.0%) and adenocarcinoma (ADC; 12.3%, 4.5%, 10.5%, 11.2%, 61.5%; p<0.001).

  • Fig. 3 Histologic type according to smoking history. ADC: adenocarcinoma, SQC: squamous cell carcinoma, NSC: non-small cell carcinoma, not otherwise specified, SCC: small cell carcinoma.

  • Fig. 4 Proportion (%) of initial treatment modalities for 1908 cases with lung cancer. BSC: best supportive care.


Cited by  1 articles

The Development of the Korean Lung Cancer Registry (KALC-R)
Young-Chul Kim, Young-Joo Won
Tuberc Respir Dis. 2019;82(2):91-93.    doi: 10.4046/trd.2018.0032.


Reference

1. Korea National Statistical Office. Death rate statistics of Korea, 2011. 2012. Daejeon: Korea National Statistical Office.
2. In KH, Kwon YS, Oh IJ, et al. Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a Korean Lung Cancer Registry Study. Lung Cancer. 2009. 64:232–237.
Article
3. Kim YC, Kwon YS, Oh IJ, et al. National survey of lung cancer in Korea, 2005. J Lung Cancer. 2007. 6:67–73.
Article
4. National Lung Screening Trial Research Team. Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011. 365:395–409.
Article
5. Lee C, Kang KH, Koh Y, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer. 2000. 30:15–22.
Article
6. Yano T, Miura N, Takenaka T, et al. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer. 2008. 113:1012–1018.
Article
7. Bryant A, Cerfolio RJ. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest. 2007. 132:185–192.
Article
8. Ferketich AK, Niland JC, Mamet R, et al. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort. Cancer. 2012. 09. 28. [Epub]. http://dx.doi.org/10.1002/cncr.27824.
Article
9. NCCN Clinical Practice Guidelines in Oncology, Lung Cancer Screening [Internet]. 2012. cited 2012 Aug 1. Fort Washington: National Comprehensive Cancer Network;Available from: http://www.nccn.com/patient-guidelines.html.
Full Text Links
  • JLC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr